Cancer is the second most common cause of death in the United States, exceeded only by heart disease. In the U.S., cancer accounts for nearly 1 of every 4 deaths.
Cancer research at the South Texas Research Facility will advance studies and patient care at the Cancer Therapy & Research Center (CTRC) at The University of Texas Health Science Center at San Antonio, South Texas’ only National Cancer Institute-designated Cancer Center.
A leader in developing new drugs to treat cancer, the CTRC Institute for Drug Development (IDD) conducts one of the largest oncology Phase I clinical drug programs in the world, and participates in development of cancer drugs approved by the U.S. Food & Drug Administration. For more information, visit www.ctrc.net.